These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36655820)

  • 1. Remote, Computerised Cognitive Assessment for Breast Cancer- and Treatment-Related Cognitive Dysfunction: Psychometric Characteristics of the Cogsuite Neurocognitive Battery.
    Root JC; Gaynor AM; Ahsan A; Jung D; Schofield E; Ryan E; Li Y; Ahles TA
    Arch Clin Neuropsychol; 2023 Jul; 38(5):699-713. PubMed ID: 36655820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel computerized neurocognitive test battery is sensitive to cancer-related cognitive deficits in survivors.
    Gaynor AM; Ahsan A; Jung D; Schofield E; Li Y; Ryan E; Ahles TA; Root JC
    J Cancer Surviv; 2024 Apr; 18(2):466-478. PubMed ID: 35939254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Convergent and criterion validity of the CogState computerized brief battery cognitive assessment in women with and without breast cancer.
    Patel SK; Meier AM; Fernandez N; Lo TTY; Moore C; Delgado N
    Clin Neuropsychol; 2017 Nov; 31(8):1375-1386. PubMed ID: 28080264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of cognitive decline in older breast cancer survivors: the Thinking and Living with Cancer study.
    McDeed AP; Van Dyk K; Zhou X; Zhai W; Ahles TA; Bethea TN; Carroll JE; Cohen HJ; Nakamura ZM; Rentscher KE; Saykin AJ; Small BJ; Root JC; Jim H; Patel SK; Mcdonald BC; Mandelblatt JS; Ahn J
    JNCI Cancer Spectr; 2024 Feb; 8(2):. PubMed ID: 38556480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associating persistent self-reported cognitive decline with neurocognitive decline in older breast cancer survivors using machine learning: The Thinking and Living with Cancer study.
    Van Dyk K; Ahn J; Zhou X; Zhai W; Ahles TA; Bethea TN; Carroll JE; Cohen HJ; Dilawari AA; Graham D; Jacobsen PB; Jim H; McDonald BC; Nakamura ZM; Patel SK; Rentscher KE; Saykin AJ; Small BJ; Mandelblatt JS; Root JC
    J Geriatr Oncol; 2022 Nov; 13(8):1132-1140. PubMed ID: 36030173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial of videoconference-delivered cognitive behavioral therapy for survivors of breast cancer with self-reported cognitive dysfunction.
    Ferguson RJ; Sigmon ST; Pritchard AJ; LaBrie SL; Goetze RE; Fink CM; Garrett AM
    Cancer; 2016 Jun; 122(11):1782-91. PubMed ID: 27135464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of semantic memory in mild cognitive impairment: The psychometric properties of a novel semantic battery.
    Ohman A; Sheppard C; Monetta L; Taler V
    Appl Neuropsychol Adult; 2022; 29(4):492-498. PubMed ID: 32546014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability, reliability, and validity of the THINC-it screening tool for cognitive impairment in depression: A psychometric exploration in healthy volunteers.
    Harrison JE; Barry H; Baune BT; Best MW; Bowie CR; Cha DS; Culpepper L; Fossati P; Greer TL; Harmer C; Klag E; Lam RW; Lee Y; Mansur RB; Wittchen HU; McIntyre RS
    Int J Methods Psychiatr Res; 2018 Sep; 27(3):e1736. PubMed ID: 30088298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Objective-subjective disparity in cancer-related cognitive impairment: does the use of change measures help reconcile the difference?
    O'Farrell E; Smith A; Collins B
    Psychooncology; 2017 Oct; 26(10):1667-1674. PubMed ID: 27278814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An initial exploration of the convergent and ecological validity of the UDS 3.0 neuropsychological battery in Parkinson's Disease.
    Lea R; Benge JF; Adler CH; Beach TG; Belden CM; Zhang N; Shill HA; Driver-Dunckley E; Mehta SH; Atri A
    J Clin Exp Neuropsychol; 2021 Nov; 43(9):918-925. PubMed ID: 35138228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating cognitive complaints in breast cancer survivors with the FACT-Cog and quantitative electroencephalography.
    Van Dyk K; Hunter AM; Ercoli L; Petersen L; Leuchter AF; Ganz PA
    Breast Cancer Res Treat; 2017 Nov; 166(1):157-166. PubMed ID: 28707203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polish validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS battery): correlation of cognitive impairment with mood disorders and fatigue.
    Betscher E; Guenter W; Langdon DW; Bonek R
    Neurol Neurochir Pol; 2021; 55(1):59-66. PubMed ID: 33047783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychometric Evaluation of the Neuropsychological Test Battery in Individuals with Normal Cognition, Mild Cognitive Impairment, or Mild to Moderate Alzheimer's Disease: Results from a Longitudinal Study.
    Harrison JE; Rentz DM; Brashear HR; Arrighi HM; Ropacki MT; Liu E
    J Prev Alzheimers Dis; 2018; 5(4):236-244. PubMed ID: 30298182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and Evaluation of a Cognitive Battery for People With Schizophrenia in Ethiopia.
    Gebreegziabhere Y; Habatmu K; Cella M; Alem A
    Schizophr Bull; 2024 Jul; 50(4):931-943. PubMed ID: 38159078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reliable change in neuropsychological assessment of breast cancer survivors.
    Andreotti C; Root JC; Schagen SB; McDonald BC; Saykin AJ; Atkinson TM; Li Y; Ahles TA
    Psychooncology; 2016 Jan; 25(1):43-50. PubMed ID: 25808921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adaptation and validation of a computerized neurocognitive battery in the Xhosa of South Africa.
    Scott JC; Moore TM; Stein DJ; Pretorius A; Zingela Z; Nagdee M; Ngqengelele L; Campbell M; Sibeko G; King MC; McClellan JM; Port AM; Jackson C; Ruparel K; Susser ES; Gur RC
    Neuropsychology; 2021 Sep; 35(6):581-594. PubMed ID: 34242045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Brief International Cognitive Assessment in Multiple Sclerosis (BICAMS): Validation in Arabic and Lebanese Normative Values.
    Darwish H; Zeinoun P; Farran N; Ghusn H; Yamout B; Khoury SJ
    J Int Neuropsychol Soc; 2022 Jan; 28(1):94-103. PubMed ID: 33563350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring cognitive complaints in breast cancer survivors: psychometric properties of the patient's assessment of own functioning inventory.
    Van Dyk K; Ganz PA; Ercoli L; Petersen L; Crespi CM
    Support Care Cancer; 2016 Dec; 24(12):4939-4949. PubMed ID: 27432402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reliability and validity of the NeuroCognitive Performance Test, a web-based neuropsychological assessment.
    Morrison GE; Simone CM; Ng NF; Hardy JL
    Front Psychol; 2015; 6():1652. PubMed ID: 26579035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.